NewswireToday - /newswire/ -
St Neots, Cambridgeshire, United Kingdom, 2011/08/18 - SonoSite's NanoMaxx proves to be an invaluable tool for determining the appropriate treatment and performing guided injections in musculoskeletal triage - Sonosite.com.
Hertfordshire Community NHS Trust’s Community Rheumatology and Pain Service has purchased a SonoSite NanoMaxx™ point-of-care ultrasound system for its musculoskeletal clinical assessment and treatment service (MSK CATS). Simon Duck, Extended Scope Practitioner – Musculoskeletal Podiatrist, explained: “We operate a musculoskeletal triage service for orthopaedic and rheumatology GP referrals and purchased the NanoMaxx to assist in performing guided injections, which would otherwise have to be done blindly or be referred to secondary care. Doppler imaging is quite helpful in this, as it is important to identify neovascularisation to determine the appropriateness of the injection. The system is portable, robust and easy to use and, used as an adjunct to our clinical skills, it will save us money in the long term.”
Dr Catherine Percy, GPwSI, Associate Specialist Rheumatology (MSK medicine), added: “The department needed a lightweight, transportable ultrasound system to complement clinical examination and assist in guided injections. We tend to see patients with problems such as tennis elbow, carpal tunnel syndrome and other soft tissue conditions, where it is useful to have access to ultrasound in your clinical practice. The NanoMaxx is very practical; we can move it around, take it in the car and the battery lasts quite a long time. It has started us on a track that is well worthwhile and will, in the future, enhance the department enormously.”
For more information about SonoSite products, please contact:
Alexander House, 40A Wilbury Way, Hitchin SG4 0AP
T +44(0)1462 444 800, F +44(0)1462 444 801 - ukresponse[.]sonosite.com sonosite.com
SonoSite, Inc. (sonosite.com) is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by fourteen subsidiaries and a global distribution network in over 100 countries. SonoSite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.
SonoSite, Ltd., a wholly owned subsidiary of SonoSite, Inc. based in Hitchin, Hertfordshire, oversees a direct sales distribution network in the UK and provides sales and marketing support for SonoSite's European offices.
© 2011 SonoSite, Inc. All rights reserved.